Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.62 |
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 5/20 | 0.44 |
| ▸ | MAOA | P21397 | 4/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18979908 | 0.89 | CYP3A4 (0.56) | CYP3A4MAPTTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL257146 | 0.88 | MAOA (0.61) | CYP3A4MAPTTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL28958670 | 0.87 | CYP3A4 (0.54) | CYP3A4MAPTTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL7062571 | 0.87 | CYP3A4 (0.59) | CYP3A4MAPTTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL4194791 | 0.84 | KCNH2 (0.52) | ALDH1A1L3MBTL1KDM4ETAAR1KCNH2 | |
| SCHEMBL2444795 | 0.84 | ALDH1A1 (0.55) | CYP3A4MAPTTDP1ALDH1A1L3MBTL1 | |
| Methane SCHEMBL28942758 | 0.82 | TDP1 (0.48) | CYP3A4MAPTTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL2440814 | 0.82 | ALDH1A1 (0.53) | CYP3A4MAPTTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL5843310 | 0.82 | CYP3A4 (0.64) | CYP3A4MAPTTDP1ALDH1A1L3MBTL1 | |
| SCHEMBL10425499 | 0.82 | KCNH2 (0.50) | ALDH1A1L3MBTL1KDM4ETAAR1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3792245-A1 | COMPOUNDS WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SAID COMPOUNDS | Eastman Chemical Company (US) | 2021-03-17 | — | — | EP | claimed |
| EP-3634937-A1 | METHODS OF MAKING COMPOUNDS AND MIXTURES HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | Eastman Chemical Company (US) | 2020-04-15 | — | — | EP | claimed |
| EP-3634938-A1 | METHODS OF MAKING COMPOUNDS AND MIXTURES HAVING AN ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | Eastman Chemical Company (US) | 2020-04-15 | — | — | EP | claimed |
| US-10428009-B2 | Methods of making compounds and mixtures having antidegradant and antifatigue efficacy | EASTMAN CHEMICAL COMPANY (US) | 2019-10-01 | — | — | US | claimed |
| US-10287418-B2 | Compounds with antidegradant and antifatigue efficacy and compositions including said compounds | EASTMAN CHEMICAL COMPANY (US) | 2019-05-14 | — | — | US | claimed |
| US-10160845-B2 | Methods of making compounds and mixtures having antidegradant and antifatigue efficacy | EASTMAN CHEMICAL COMPANY (US) | 2018-12-25 | — | — | US | claimed |
| WO-2018226375-A1 | METHODS OF MAKING COMPOUNDS AND MIXTURES HAVING AN ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | EASTMAN CHEMICAL COMPANY (US) | 2018-12-13 | — | — | WO | claimed |
| WO-2018226376-A1 | METHODS OF MAKING COMPOUNDS AND MIXTURES HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | EASTMAN CHEMICAL COMPANY (US) | 2018-12-13 | — | — | WO | claimed |
| EP-3394028-A1 | COMPOUNDS WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SAID COMPOUNDS | Eastman Chemical Company (US) | 2018-10-31 | — | — | EP | claimed |
| US-20170275233-A1 | METHODS OF MAKING COMPOUNDS AND MIXTURES HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | EASTMAN CHEMICAL COMPANY (US) | 2017-09-28 | — | — | US | claimed |
| US-20170275238-A1 | METHODS OF MAKING COMPOUNDS AND MIXTURES HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | EASTMAN CHEMICAL COMPANY (US) | 2017-09-28 | — | — | US | claimed |
| WO-2017112440-A1 | COMPOUNDS WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SAID COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2017-06-29 | — | — | WO | claimed |
| US-20170174615-A1 | COMPOUNDS WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SAID COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2017-06-22 | — | — | US | claimed |
| EP-3634939-B1 | METHODS OF MAKING COMPOUNDS HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | EASTMAN CHEM CO (US) | 2021-03-24 | — | — | EP | disclosed |
| EP-3792245-A1 | COMPOUNDS WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SAID COMPOUNDS | Eastman Chemical Company (US) | 2021-03-17 | — | — | EP | disclosed |
| EP-3394028-B1 | COMPOUNDS WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SAID COMPOUNDS | EASTMAN CHEM CO (US) | 2020-11-04 | — | — | EP | disclosed |
| US-20170275234-A1 | METHODS OF MAKING COMPOUNDS HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | EASTMAN CHEMICAL COMPANY (US) | 2017-09-28 | — | — | US | disclosed |
| US-20170275238-A1 | METHODS OF MAKING COMPOUNDS AND MIXTURES HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | EASTMAN CHEMICAL COMPANY (US) | 2017-09-28 | — | — | US | disclosed |
| WO-2017112440-A1 | COMPOUNDS WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SAID COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2017-06-29 | — | — | WO | disclosed |
| US-20170174615-A1 | COMPOUNDS WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SAID COMPOUNDS | EASTMAN CHEMICAL COMPANY (US) | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10428009-B2 | Methods of making compounds and mixtures having antidegradant and antifatigue efficacy | ACHE, DDO, BCHE | CYP3A4 498/4885MAPT 1163/4885TDP1 116/4885 |
| US-10160845-B2 | Methods of making compounds and mixtures having antidegradant and antifatigue efficacy | ACHE, BCHE, DDO | CYP3A4 468/4885MAPT 1096/4885TDP1 61/4885 |
| US-20170275234-A1 | METHODS OF MAKING COMPOUNDS HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | ACHE, HNMT, PNMT | CYP3A4 555/4885MAPT 1355/4885TDP1 91/4885 |
| US-20170275238-A1 | METHODS OF MAKING COMPOUNDS AND MIXTURES HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | ACHE, BCHE, DDO | CYP3A4 468/4885MAPT 1096/4885TDP1 61/4885 |
| US-20170174615-A1 | COMPOUNDS WITH ANTIDEGRADANT AND ANTIFATIGUE EFFICACY AND COMPOSITIONS INCLUDING SAID COMPOUNDS | ACHE, HDAC3, PON1 | CYP3A4 166/4885MAPT 2400/4885TDP1 95/4885 |
| US-20170275233-A1 | METHODS OF MAKING COMPOUNDS AND MIXTURES HAVING ANTIDEGRADANT AND ANTIFATIGUE EFFICACY | ACHE, DDO, BCHE | CYP3A4 498/4885MAPT 1163/4885TDP1 116/4885 |
| US-10287418-B2 | Compounds with antidegradant and antifatigue efficacy and compositions including said compounds | ACHE, HDAC3, PON1 | CYP3A4 166/4885MAPT 2400/4885TDP1 95/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.